RSNA: Opportunistic Assessment of Aortic Calcium Predicts MACE
MONDAY, Dec. 9, 2024 -- A fully automated algorithm to quantify aortic artery calcification (AAC) on computed tomography (CT) scans performed for other clinical purposes (opportunistic CT) can predict the risk for subsequent major adverse cardiovascular events (MACE), according to a study presented at the annual meeting of the Radiological Society of North America, held from Dec. 1 to 5 in Chicago.
Miriam A. Bredella, M.D., from NYU Langone Health in New York City, and colleagues examined the clinical utility of fully automated AAC quantification for the development of MACE. A fully automated artificial intelligence (AI) algorithm to quantify AAC using the Agatston score was retrospectively applied to 3,662 patients with evaluable abdominal CT and cardiac CT.
The researchers observed a positive correlation between the presence of coronary artery calcium and AAC (r = 0.56). In 324 patients (9 percent), MACE occurred after CT. In the AAC-absent and AAC-present groups, the incidence of MACE was 0.85 and 2.85 per 1,000 person-months, respectively. The presence of AAC was associated with a significant risk for MACE after adjustment for age, sex, race/ethnicity, body mass index, diabetes mellitus, hypertension, and statin use (adjusted hazard ratio, 2.24).
"Instead of relying on dedicated CT scans of coronary arteries, which are rare and not always covered by insurance, to find potentially fatal heart disease, we seek to use AI to help screen abdominal CT scans that are done for many reasons to opportunistically catch heart disease more often and earlier," Bredella said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
Elderly Patients Benefit From Screening Mammography
WEDNESDAY, Oct. 1, 2025 -- Patients with breast cancer diagnosed at 80 years of age or older who received screening mammography present with earlier-stage disease and have better...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.